30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Paul Meister

Track

Insider profile

Currently holds positions in Amneal Pharmaceuticals Inc, Light & Wonder Inc, Quanterix Corp and Aptiv PLC

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 19% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Amneal Pharmaceuticals Inc Aug. 3, 2019 -
Independent Director Light & Wonder Inc March 20, 2012 -
Independent Director Quanterix Corp Sept. 1, 2013 -
Independent Director Aptiv PLC July 25, 2019 -
Director Revlon Inc Nov. 13, 2018 - June 6, 2019
Executive Vice Chairman of the Board Revlon Inc Jan. 28, 2018 - Nov. 13, 2018
Director vTv Therapeutics Inc July 1, 2015 - Sept. 28, 2018
Independent Director LKQ Corp Feb. 1, 1999 - May 7, 2018
Director Revlon Inc June 1, 2016 - Jan. 28, 2018
Director Syneos Health Us Inc Sept. 1, 2014 - Sept. 30, 2016
Chairman of the Board, Chief Executive Officer Syneos Health Us Inc Feb. 1, 2011 - Sept. 1, 2014
Paul Meister's trades of Quanterix Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-10 2022-08-10
B Purchase
27,397 -15.7%
491.60
US$1,967,838 		27,397 -15.7% 491.60 US$1,967,838
2022-08-10 2022-08-10
B Purchase
30,328 +21.4%
325.65
US$4,900,304 		30,328 +21.4% 325.65 US$4,900,304
2020-03-19 2020-03-18
B Purchase
27,914 -13.2%
170.84
US$1,246,132 		27,914 -13.2% 170.84 US$1,246,132
2020-03-19 2020-03-17
B Purchase
149,439 +inf%
2.79
US$416,935 		149,439 +inf% 2.79 US$416,935